Q3 2017 Holdings
Filed 2017-11-13 | 20 holdings | $21.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $10.3M | 285,143 | 48.2% |
| Aclaris Therapeutics, Inc.(ACRS) | COM | 00461U105 | $6.8M | 262,950 | 31.6% |
| argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $4.0M | 176,500 | 18.6% |
| Aerie Pharmaceuticals, Inc.(AERIEUR) | COM | 00771V108 | $94.8K | 1,950,477 | 0.4% |
| Alder BioPharmaceuticals, Inc.(ALDR1EUR) | COM | 014339105 | $36.0K | 2,942,203 | 0.2% |
| Immunomedics, Inc.(IMMU) | COM | 452907108 | $33.3K | 2,379,367 | 0.2% |
| Blueprint Medicines Corporation(2L9) | COM | 09627Y109 | $32.6K | 467,682 | 0.2% |
| Achaogen, Inc. | COM | 004449104 | $30.5K | 1,912,106 | 0.1% |
| Aimmune Therapeutics, Inc.(AIMT) | COM | 00900T107 | $22.6K | 912,001 | 0.1% |
| Wave Life Sciences Ltd.(WVE) | SHS | Y95308105 | $18.8K | 863,327 | 0.1% |
| Epizyme, Inc.(EPZMEUR) | COM | 29428V104 | $16.2K | 849,693 | 0.1% |
| Myokardia, Inc. | COM | 62857M105 | $12.6K | 295,000 | 0.1% |
| Acceleron Pharma Inc.(XLRN) | COM | 00434H108 | $10.4K | 278,753 | 0.0% |
| Verona Pharma Plc(VRNA) | SPONSORED ADS | 925050106 | $9.3K | 608,851 | 0.0% |
| Pacific Biosciences of California, Inc.(PACB) | COM | 69404D108 | $6.0K | 1,150,000 | 0.0% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | COM | 23257D103 | $4.8K | 600,000 | 0.0% |
| Loxo Oncology, Inc. | COM | 548862101 | $4.6K | 50,000 | 0.0% |
| Madrigal Pharmaceuticals, Inc.(MDGL) | COM | 558868105 | $4.5K | 100,000 | 0.0% |
| Tocagen, Inc. | COM | 888846102 | $3.7K | 293,177 | 0.0% |
| Dermira, Inc.(DERMEUR) | COM | 24983L104 | $1.2K | 43,071 | 0.0% |